Form 8-K - Current report:
SEC Accession No. 0001493152-24-030540
Filing Date
2024-08-07
Accepted
2024-08-07 15:37:50
Documents
19
Period of Report
2024-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39459
2 ex4-1.htm EX-4.1 18856
3 ex4-1_001.jpg GRAPHIC 3756
4 ex4-1_002.jpg GRAPHIC 15195
5 ex4-1_003.jpg GRAPHIC 5234
6 ex4-1_004.jpg GRAPHIC 3255
7 ex4-1_005.jpg GRAPHIC 6088
  Complete submission text file 0001493152-24-030540.txt   275491

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ppcb-20240801.xsd EX-101.SCH 3012
9 XBRL LABEL FILE ppcb-20240801_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE ppcb-20240801_pre.xml EX-101.PRE 22357
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3334
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 241183299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)